Share this article

print logo

Pence plans at least two events in Buffalo today, Cuomo also in town

Vice President Pence is scheduled to arrive in Buffalo a little before noon today for two events, but Gov. Andrew Cuomo also is planning a morning appearance here.

Pence has scheduled a meeting with business executives and “New York families” for a discussion on tax reform and also for a fundraiser for Rep. Chris Collins of Clarence. He's also expected to visit Performance Advantage, a tool mounting company in Lancaster.

Protesters are expected to demonstrate on the sidewalks outside Salvatore's Italian Gardens, where the fundraiser is being held.

Elsewhere in Buffalo this morning, Cuomo will make an announcement at the new John R. Oishei Children's Hospital. There is no word on what that announcement will be.

The discussion on tax reform with business and families drew early criticism from Senate Minority Leader Charles E. Schumer, who lashed out Monday about Pence's pending visit.

"When Vice President Pence arrives in Buffalo I hope he’s prepared to explain why he wants to hike taxes on thousands of middle class families in Western New York and across New York State,’’ Schumer said Monday afternoon in an interview.

A key way the White House and many congressional Republicans plan to pay for a recently proposed tax package is eliminating federal deductions for state and local taxes. It would provide an estimated $1.3 trillion to fund the tax plan Republicans hope to pass before the end of the year.

New York residents are a major user of the deduction, and the state has estimated 3.3 million New York filers would see a tax increase, totaling an extra $17.5 billion for Washington.

Schumer wants Pence to explain plan to end tax deduction popular in New York

Pence's visit comes less than a week after the Office of Congressional Ethics said there was a “substantial reason to believe” that Collins violated federal law and House rules for possibly sharing insider information with investors about an Australian pharmaceutical company. The investigation is ongoing.




There are no comments - be the first to comment